Cite

HARVARD Citation

    Fazio, N. et al. (2018). Everolimus in advanced, progressive, well‐differentiated, non‐functional neuroendocrine tumors: RADIANT‐4 lung subgroup analysis. Cancer science. 109 (1), pp. 174-181. [Online]. 
  
Back to record